FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076245797> ?p ?o ?g. }

• W2076245797 endingPage "S132" @default.
• W2076245797 startingPage "S131" @default.
• W2076245797 abstract "Purpose/Objective(s)The importance of patient-reported outcomes (PRO) including QOL domains has been shown in clinical trials involving head and neck cancer patients, but no studies have evaluated PRO data collection in a radiation oncology practice for those undergoing radiation therapy (RT). A pilot study was performed to determine if electronic real-time PRO collection can be collected and effectively used by the RT team in patient care. As part of the pilot, PRO and QOL data was collected on head and neck cancer patients receiving RT ± chemotherapy.Materials/MethodsA two-arm, longitudinal design study with 132 patients including 72 head and neck cancer patients receiving curative RT ± chemotherapy was conducted between 2008 and 2011. Thirty-eight patients (53%) were treated with concurrent chemo-radiation (CRT) and 34 patients (47%) with RT alone. At baseline prior to RT and weeks 1, 3, 5 and last week of RT, patients completed a web based, electronic 12 item Linear Analogue Self-Assessment tool. The Interpersonal Patient-Provider Relationship Scale and the Was it Worth It questionnaire were completed during the last week of RT. Data collection occurred in two phases: control (35 patients) and active intervention groups (37 patients). In the control phase, clinicians were blind to the data prior to conducting the on treatment visit. In the active intervention phase, data were available electronically for the clinicians to assist with clinical care. Changes in QOL domains from baseline to last week of RT (including those completed 5 weeks or 7 weeks RT) were compared between RT ± chemotherapy groups via Wilcoxon methodology.ResultsOn a scale of 0 to 100, head and neck patients reported a ≥ 9 point decline in overall QOL, mental well-being (WB), physical WB, social activity, pain frequency/severity and fatigue from baseline to last week of RT. Overall QOL (p = 0.037), social activity (p = 0.005), pain frequency/severity (p = 0.004) and fatigue (p = 0.009) were significantly worse in patients receiving CRT compared to RT alone at last week of RT. Seventy-five percent of patients felt that participation in the study was worthwhile and 94% would participate again.ConclusionsThis study represented the first reported use of electronic collection of real-time QOL data during a course of RT for H& N cancer patients. We have identified significant decreases in QOL domains which worsen during the course of therapy including those not commonly evaluated such as mental and social WB. We have demonstrated that real-time collection of QOL data is feasible, acceptable to head and neck patients, and provides patient reported information of importance to clinical care. Purpose/Objective(s)The importance of patient-reported outcomes (PRO) including QOL domains has been shown in clinical trials involving head and neck cancer patients, but no studies have evaluated PRO data collection in a radiation oncology practice for those undergoing radiation therapy (RT). A pilot study was performed to determine if electronic real-time PRO collection can be collected and effectively used by the RT team in patient care. As part of the pilot, PRO and QOL data was collected on head and neck cancer patients receiving RT ± chemotherapy. The importance of patient-reported outcomes (PRO) including QOL domains has been shown in clinical trials involving head and neck cancer patients, but no studies have evaluated PRO data collection in a radiation oncology practice for those undergoing radiation therapy (RT). A pilot study was performed to determine if electronic real-time PRO collection can be collected and effectively used by the RT team in patient care. As part of the pilot, PRO and QOL data was collected on head and neck cancer patients receiving RT ± chemotherapy. Materials/MethodsA two-arm, longitudinal design study with 132 patients including 72 head and neck cancer patients receiving curative RT ± chemotherapy was conducted between 2008 and 2011. Thirty-eight patients (53%) were treated with concurrent chemo-radiation (CRT) and 34 patients (47%) with RT alone. At baseline prior to RT and weeks 1, 3, 5 and last week of RT, patients completed a web based, electronic 12 item Linear Analogue Self-Assessment tool. The Interpersonal Patient-Provider Relationship Scale and the Was it Worth It questionnaire were completed during the last week of RT. Data collection occurred in two phases: control (35 patients) and active intervention groups (37 patients). In the control phase, clinicians were blind to the data prior to conducting the on treatment visit. In the active intervention phase, data were available electronically for the clinicians to assist with clinical care. Changes in QOL domains from baseline to last week of RT (including those completed 5 weeks or 7 weeks RT) were compared between RT ± chemotherapy groups via Wilcoxon methodology. A two-arm, longitudinal design study with 132 patients including 72 head and neck cancer patients receiving curative RT ± chemotherapy was conducted between 2008 and 2011. Thirty-eight patients (53%) were treated with concurrent chemo-radiation (CRT) and 34 patients (47%) with RT alone. At baseline prior to RT and weeks 1, 3, 5 and last week of RT, patients completed a web based, electronic 12 item Linear Analogue Self-Assessment tool. The Interpersonal Patient-Provider Relationship Scale and the Was it Worth It questionnaire were completed during the last week of RT. Data collection occurred in two phases: control (35 patients) and active intervention groups (37 patients). In the control phase, clinicians were blind to the data prior to conducting the on treatment visit. In the active intervention phase, data were available electronically for the clinicians to assist with clinical care. Changes in QOL domains from baseline to last week of RT (including those completed 5 weeks or 7 weeks RT) were compared between RT ± chemotherapy groups via Wilcoxon methodology. ResultsOn a scale of 0 to 100, head and neck patients reported a ≥ 9 point decline in overall QOL, mental well-being (WB), physical WB, social activity, pain frequency/severity and fatigue from baseline to last week of RT. Overall QOL (p = 0.037), social activity (p = 0.005), pain frequency/severity (p = 0.004) and fatigue (p = 0.009) were significantly worse in patients receiving CRT compared to RT alone at last week of RT. Seventy-five percent of patients felt that participation in the study was worthwhile and 94% would participate again. On a scale of 0 to 100, head and neck patients reported a ≥ 9 point decline in overall QOL, mental well-being (WB), physical WB, social activity, pain frequency/severity and fatigue from baseline to last week of RT. Overall QOL (p = 0.037), social activity (p = 0.005), pain frequency/severity (p = 0.004) and fatigue (p = 0.009) were significantly worse in patients receiving CRT compared to RT alone at last week of RT. Seventy-five percent of patients felt that participation in the study was worthwhile and 94% would participate again. ConclusionsThis study represented the first reported use of electronic collection of real-time QOL data during a course of RT for H& N cancer patients. We have identified significant decreases in QOL domains which worsen during the course of therapy including those not commonly evaluated such as mental and social WB. We have demonstrated that real-time collection of QOL data is feasible, acceptable to head and neck patients, and provides patient reported information of importance to clinical care. This study represented the first reported use of electronic collection of real-time QOL data during a course of RT for H& N cancer patients. We have identified significant decreases in QOL domains which worsen during the course of therapy including those not commonly evaluated such as mental and social WB. We have demonstrated that real-time collection of QOL data is feasible, acceptable to head and neck patients, and provides patient reported information of importance to clinical care." @default.
• W2076245797 created "2016-06-24" @default.
• W2076245797 creator A5018137795 @default.
• W2076245797 creator A5028356321 @default.
• W2076245797 creator A5029960111 @default.
• W2076245797 creator A5045097402 @default.
• W2076245797 creator A5070154863 @default.
• W2076245797 creator A5090700846 @default.
• W2076245797 date "2013-10-01" @default.
• W2076245797 modified "2023-10-18" @default.
• W2076245797 title "Real-Time Assessment of Patient-Reported Outcomes in Head-and-Neck Cancer Patients Undergoing Radiation Therapy" @default.
• W2076245797 doi "https://doi.org/10.1016/j.ijrobp.2013.06.340" @default.
• W2076245797 hasPublicationYear "2013" @default.
• W2076245797 type Work @default.
• W2076245797 sameAs 2076245797 @default.
• W2076245797 citedByCount "0" @default.
• W2076245797 crossrefType "journal-article" @default.
• W2076245797 hasAuthorship W2076245797A5018137795 @default.
• W2076245797 hasAuthorship W2076245797A5028356321 @default.
• W2076245797 hasAuthorship W2076245797A5029960111 @default.
• W2076245797 hasAuthorship W2076245797A5045097402 @default.
• W2076245797 hasAuthorship W2076245797A5070154863 @default.
• W2076245797 hasAuthorship W2076245797A5090700846 @default.
• W2076245797 hasBestOaLocation W20762457971 @default.
• W2076245797 hasConcept C126838900 @default.
• W2076245797 hasConcept C141071460 @default.
• W2076245797 hasConcept C143998085 @default.
• W2076245797 hasConcept C2776530083 @default.
• W2076245797 hasConcept C3018411727 @default.
• W2076245797 hasConcept C509974204 @default.
• W2076245797 hasConcept C71924100 @default.
• W2076245797 hasConceptScore W2076245797C126838900 @default.
• W2076245797 hasConceptScore W2076245797C141071460 @default.
• W2076245797 hasConceptScore W2076245797C143998085 @default.
• W2076245797 hasConceptScore W2076245797C2776530083 @default.
• W2076245797 hasConceptScore W2076245797C3018411727 @default.
• W2076245797 hasConceptScore W2076245797C509974204 @default.
• W2076245797 hasConceptScore W2076245797C71924100 @default.
• W2076245797 hasIssue "2" @default.
• W2076245797 hasLocation W20762457971 @default.
• W2076245797 hasOpenAccess W2076245797 @default.
• W2076245797 hasPrimaryLocation W20762457971 @default.
• W2076245797 hasRelatedWork W1979477723 @default.
• W2076245797 hasRelatedWork W1993267564 @default.
• W2076245797 hasRelatedWork W2050191904 @default.
• W2076245797 hasRelatedWork W2092390197 @default.
• W2076245797 hasRelatedWork W2099667649 @default.
• W2076245797 hasRelatedWork W2528914879 @default.
• W2076245797 hasRelatedWork W2529376761 @default.
• W2076245797 hasRelatedWork W2601224035 @default.
• W2076245797 hasRelatedWork W2949481397 @default.
• W2076245797 hasRelatedWork W3045606121 @default.
• W2076245797 hasVolume "87" @default.
• W2076245797 isParatext "false" @default.
• W2076245797 isRetracted "false" @default.
• W2076245797 magId "2076245797" @default.
• W2076245797 workType "article" @default.